Avantor Recalls Magnesium Sulfate 7-Hydrate Due to Impurity Failures
Avantor Performance Materials is recalling 265 drums of Magnesium Sulfate 7-Hydrate for parenteral use because the product failed impurity specifications.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences.
Plain-English summary
Avantor Performance Materials, Inc. is recalling 265 drums of Magnesium Sulfate 7-Hydrate, (For Parenteral Use) USP -GenAR, 100LB. The recall was initiated because the product failed impurities/degradation specifications, resulting in out-of-specifications results for impurities.
The affected product is distributed in the US, including California, Illinois, and North Carolina, as well as in Canada. The recall covers two specific lots: Lot #0000115590 and Lot #0000117563, both with an expiration date of 5/10/17.
This is an FDA Class III recall, which indicates that the use of or exposure to the product is not likely to cause adverse health consequences. Consumers and healthcare providers should stop using the affected lots and contact the manufacturer for further instructions.
The recalled product
- Product
- Magnesium Sulfate 7-Hydrate, (For Parenteral Use) USP -GenAR, 100LB, Avantor Performance Materials, Inc., 3472 Corporate Parkway, Suite 200 Center Valley, PA 18034. 610-573-2600.
- Manufacturer
- Avantor Performance Materials Inc
- Category
- Drug — Pharmaceutical Ingredient
- Hazard
- Affected units
- 265
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 0000115590
- Expiry: 5/10/17
- Lot #: 0000117563
- Expiry: 5/10/17.
Distribution
Related recalls
Same manufacturer · Avantor Performance Materials Inc
See all →- ModerateAvantor Recalls Potassium Phosphate Bulk Chemical for Excess Iron Content
FDA (Drugs) · 2019-12-04
Same hazard · impurities
See all →- LowDabigatran Etexilate Capsules Recalled Due to Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- ModerateGlycopyrrolate Oral Solution Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-29
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateMethohexital Sodium 100 mg/10 mL Compounded Drug Recalled Nationwide
FDA (Drugs) · 2026-07-15
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08